发明名称 PLATELET ADP RECEPTOR INHIBITOR
摘要 <p><P>PROBLEM TO BE SOLVED: To provide a platelet ADP receptor inhibitor having anti-thrombotic activity and useful for preventing and/or treating cardiovascular diseases, particularly thrombosis-related diseases. <P>SOLUTION: New compounds expressed by formula (I)-formula (VIII) are provided. More concretely, sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives and acylsulfonamide derivatives which are effective platelet ADP receptor inhibitors are cited. These derivatives can be used in various pharmaceutical compositions and are particularly effective for preventing and/or treating cardiovascular diseases (particularly cardiovascular diseases associated with thrombosis). A method for preventing or treating thrombosis in mammals is also provided. The method includes a process for administering a therapeutically effective amount of the compounds represented by formula (I)-formula (VIII) or their pharmaceutically acceptable salts. <P>COPYRIGHT: (C)2010,JPO&INPIT</p>
申请公布号 JP2010155860(A) 申请公布日期 2010.07.15
申请号 JP20100076428 申请日期 2010.03.29
申请人 PORTOLA PHARMACEUTICALS INC 发明人 SCARBOROUGH ROBERT M;JANTZEN HANS-MICHAEL;HUANG WOLIN;SEDLOCK DAVID M;MARLOWE CHARLES K;KANE-MAGUIRE KIM A
分类号 C07D239/48;C07D239/96;A61K31/16;A61K31/175;A61K31/381;A61K31/4035;A61K31/404;A61K31/41;A61K31/4196;A61K31/4436;A61K31/4709;A61K31/4725;A61K31/4745;A61K31/502;A61K31/505;A61K31/517;A61K31/519;A61K31/5377;A61K31/54;A61K31/549;A61K31/55;A61K31/5513;A61K31/64;A61P7/02;A61P9/00;A61P9/04;A61P9/10;A61P9/14;A61P15/00;A61P43/00;C07D209/48;C07D213/70;C07D239/22;C07D239/50;C07D333/34;C07D401/04;C07D401/12;C07D405/12;C07D409/12;C07D409/14;C07D413/14;C07D417/12;C07D471/04;C07D487/04;C07D495/04;C07D498/04;C07D513/04;C07D521/00 主分类号 C07D239/48
代理机构 代理人
主权项
地址